Tasly Capital
Asia, Guangdong, China, Tianjin'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Tasly Capital is an investment arm of Tasly, a Chinese pharmaceutical company.
Investor Profile
Tasly Capital has backed more than 5 startups, with 2 new investments in the last 12 months alone. The firm has led 2 rounds, about 40% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Series C rounds (top funding stages).
- Majority of deals are located in China.
- Strong thematic focus on Medical, Biotechnology, Health Care.
- Led 2 rounds in the past year.
Stage Focus
- Series B (40%)
- Series A (40%)
- Series C (20%)
Country Focus
- China (100%)
Industry Focus
- Medical
- Biotechnology
- Health Care
- Manufacturing
- Medical Device
- Biopharma
- Pharmaceutical
- Hospital
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
